PPARA and glioblastoma: Moreover, PPARα contributes to TMZ-induced GBM growth arrest by inhibiting H3K18la, and targeting PPARα with lipid-lowering agent gemfibrozil can effectively reverse the acquired resistance via H3K18la suppression [61].